Is investing in medicines harming the health of the UK population?
A recent study published in the Lancet has disputed the existing decision-making threshold used by NICE. The authors argue that allowing NHS patients access to new NICE-recommended medicines has…
Read the full articleYou might also wanna read
iRacing Subscription Price Increase (August 2026): How to Lock in Current Rates
BoxThisLap·17h ago
New York Fed Finds Tariff-Driven Price Hikes Will Stretch Past 2026
PYMNTS·2d ago
Why the government must urgently raise the NICE cost-effectiveness threshold
ABPI·2d ago
Understanding NHS medicines spending in England
ABPI·2d ago
New ORA 5 SUV lands in SA with petrol, hybrid, and EV models from R365k
htxt.co.za·2d ago
Updates to the NHS Commercial Framework must deliver more flexibility to support timely access to medicines
ABPI·3d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.